{{Rsnum
|rsid=151222
|Gene=ACSM1
|Chromosome=16
|position=20663170
|Orientation=plus
|GMAF=0.09045
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=ACSM1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 0.9 | 13.3 | 85.8
| HCB | 3.6 | 32.8 | 63.5
| JPT | 2.7 | 17.7 | 79.6
| YRI | 0.0 | 3.4 | 96.6
| ASW | 0.0 | 8.8 | 91.2
| CHB | 3.6 | 32.8 | 63.5
| CHD | 5.5 | 37.6 | 56.9
| GIH | 3.0 | 30.7 | 66.3
| LWK | 0.0 | 3.6 | 96.4
| MEX | 0.0 | 8.6 | 91.4
| MKK | 0.0 | 7.7 | 92.3
| TSI | 0.0 | 12.7 | 87.3
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs151222
|PubMedID=18347602
|Condition=Schizophrenia
|Gene=ACSM1, BUCS1
|Risk Allele=
|pValue=6.00E-006
|OR=2.1
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs151222
|Name_s=
|Gene_s=ACSM1
|Feature=
|Evidence=PubMed ID:18347602; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genomewide association for schizophrenia in the CATIE study: results of stage 1 (Initial Sample Size: 738 cases, 733 controls; Replication Sample Size: NR). This variant is associated with Schizophrenia.
|Drugs=
|Drug Classes=
|Diseases=Schizophrenia
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356466
}}

{{PMID Auto
|PMID=19197363
|Title=A genome-wide investigation of SNPs and CNVs in schizophrenia.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs151222
|overall_frequency_n=9
|overall_frequency_d=128
|overall_frequency=0.0703125
|n_genomes=7
|n_genomes_annotated=0
|n_haplomes=7
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}